300347

Hangzhou Tigermed Consulting
300347

Last Price

Income Statement

Income Statement
Metric2009201020112012201320142015201620172018201920202021202220232024LTM
CN¥7.384BCN¥6.603BCN¥6.495B
CN¥4.539BCN¥4.359BCN¥4.606B
CN¥2.845BCN¥2.244BCN¥1.889B
CN¥261.555MCN¥238.386MCN¥240.696M
CN¥837.516MCN¥944.45MCN¥929.652M
CN¥-740.655MCN¥396.994MCN¥297.225M
CN¥2.487BCN¥0.664BCN¥0.422B
CN¥105.715MCN¥-56.089MCN¥143.893M
CN¥-104.122MCN¥56.131MCN¥-148.443M
CN¥1.593MCN¥0.042MCN¥-4.55M
CN¥2.489BCN¥0.664BCN¥0.417B
CN¥338.606MCN¥216.63MCN¥163.977M
CN¥2.025BCN¥0.405BCN¥0.296B
CN¥2.34CN¥0.47CN¥0.349
CN¥2.34CN¥0.47CN¥0.349
CN¥0.865BCN¥0.862BCN¥3.44B
CN¥0.865BCN¥0.862BCN¥3.44B
CN¥1.876BCN¥1.215BCN¥0.872B
CN¥185.057MCN¥205.221MCN¥201.134M
CN¥1.69BCN¥1.009BCN¥0.671B

Revenue And Expenses Breakdown

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.